[1] ANAM AK, INSOGNA K. Update on Osteoporosis Screening and Management. Med Clin North Am. 2021;105(6):1117-1134.
[2] SU Y, CHEN Z, XIE W. Swimming as Treatment for Osteoporosis: A Systematic Review and Meta-analysis. Biomed Res Int. 2020;2020:6210201.
[3] Management of Osteoporosis in Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society’’ Editorial Panel. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973-997.
[4] WANG Y, KANNEGANTI TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641-4657.
[5] MALIREDDI RKS, KESAVARDHANA S, KANNEGANTI TD. ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406.
[6] SAMIR P, MALIREDDI RKS, KANNEGANTI TD. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:238.
[7] PANDIAN N, KANNEGANTI TD. PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality. J Immunol. 2022;209(9):1625-1633.
[8] JIANG N, AN J, YANG K, et al. NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis? Front Endocrinol (Lausanne). 2021;12:752546.
[9] HE B, ZHU Y, CUI H, et al. Comparison of Necroptosis With Apoptosis for OVX-Induced Osteoporosis. Front Mol Biosci. 2021;8:790613.
[10] WEI S, CHEN Z, LING X, et al. Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments. Front Pharmacol. 2023;14:1115221.
[11] COMPSTON JE, MCCLUNG MR, LESLIE WD. Osteoporosis. Lancet. 2019; 393(10169):364-376.
[12] LI SS, HE SH, XIE PY, et al. Recent Progresses in the Treatment of Osteoporosis. Front Pharmacol. 2021;12:717065.
[13] 中华医学会骨质疏松和骨矿盐疾病分会,章振林.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[14] 冉栋成,王槐骏,杨城,等.坏死性凋亡与骨质疏松症机制研究[J].中国骨质疏松杂志,2023,29(5):745-750.
[15] ZHENG M, KANNEGANTI TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297(1):26-38.
[16] CHRISTGEN S, TWEEDELL RE, KANNEGANTI TD. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232:108010.
[17] CHI D, ZHANG Y, LIN X, et al. Caspase-1 Inhibition Reduces Occurrence of PANoptosis in Macrophages Infected by E. faecalis OG1RF. J Clin Med. 2022;11(20):6204.
[18] ZHANG J, WEI K. Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3/caspase-1/GSDMD pathway. Exp Cell Res. 2021;405(2):112648.
[19] CHO M, DHO SH, SHIN S, et al. Caspase-10 affects the pathogenesis of primary biliary cholangitis by regulating inflammatory cell death. J Autoimmun. 2022;133:102940.
[20] TANZER MC, KHAN N, RICKARD JA, et al. Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death Differ. 2017;24(3):481-491.
[21] WANG T, HE C. TNF-α and IL-6: The Link between Immune and Bone System. Curr Drug Targets. 2020;21(3):213-227.
[22] KARKI R, SHARMA BR, TULADHAR S, et al. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2021;184(1):149-168.e17.
[23] BERKDEMIR SIVEREKLI N, SAHIN O, SENEL S, et al. Bone mineral density in familial Mediterranean fever. Rheumatol Int. 2012;32(8):2453-2457.
[24] SCHNAPPAUF O, CHAE JJ, KASTNER DL, et al. The Pyrin Inflammasome in Health and Disease. Front Immunol. 2019;10:1745.
[25] AL-BARGHOUTHI BM, FARBER CR. Dissecting the Genetics of Osteoporosis using Systems Approaches. Trends Genet. 2019;35(1):55-67.
[26] SONG S, GUO Y, YANG Y, et al. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022;237:108168.
[27] 郑峰,王福荣,许喆.维生素D受体基因多态性与青海地区藏族绝经后女性骨质疏松性骨折易感性的关系[J].中国现代医学杂志,2021, 31(20):35-41.
[28] 李丽生,何梦娇,骆凯,等.Ⅰ型胶原及骨膜蛋白在骨质疏松大鼠骨髓基质细胞膜片中的表达研究[J].中外医学研究,2022,20(29):151-155.
[29] OGURA K, IIMURA T, MAKINO Y, et al. Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone. Bone Rep. 2016;5:7-14.
[30] HU Y, HAN J, DING S, et al. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. Front Endocrinol (Lausanne). 2022;13:986384.
[31] 张倩,王花欣,王媛, 等.中药防治绝经后骨质疏松症的研究进展[J].中国骨质疏松杂志,2020,26(7):1083-1088.
|